2020年12月最新中科院JCR期刊分区数据【基础版、升级版（试行）】均已更新，欢迎查询使用！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 期刊名字 | INTERNATIONAL IMMUNOPHARMACOLOGY INT IMMUNOPHARMACOL 6.7 我要评分
声誉 7.5 影响力 5.4 速度 9.4 | |||||||||||||||||||||||||
| 期刊ISSN | 1567-5769 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| E-ISSN | 1878-1705 | |||||||||||||||||||||||||
| 2019-2020自引率 | 6.50%登录查看自引率趋势图 | |||||||||||||||||||||||||
| h-index | 98 | |||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/621330/description#description | |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/INTIMP | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||||||||||
| 出版商 | Elsevier | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-免疫学 | |||||||||||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 2001 | |||||||||||||||||||||||||
| 年文章数 | 679登录查看年文章数趋势图 | |||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 （ 2021年1月发布版） | 不在预警名单中 | |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月最新基础版） | 登录查看中科院JCR分区趋势图
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月最新升级版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年1月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊coverage | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2.7个月 来源Elsevier官网： 平均7.5周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约81.66% | |||||||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均2.7周 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 登录查看自引率趋势图 |
| 登录查看中科院JCR分区趋势图 |
| 登录查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats Author: Lei Zhu, PeiQing Gu, Hong Shen Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 242-251, DOI:10.1016/j.intimp.2018.12.036 DOI |
| 2. | Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1 Author: Hui Wu, Heng Fan, Zhexing Shou, Meng Xu, Qianyun Chen, Changzheng Ai, Yalan Dong, Yujin Liu, Zhen Nan, Yifan Wang, Ting Yu, Xingxing Liu Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 204-212, DOI:10.1016/j.intimp.2018.12.043 DOI |
| 3. | Protective effects of alogliptin against TNF-α-induced degradation of extracellular matrix in human chondrocytes Author: Panpan Zhang, Yuhua Chen, Huafei Zhao, Hao Du Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 179-184, DOI:10.1016/j.intimp.2018.11.007 DOI |
| 4. | Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis Author: Shuyao Hua, Mingyang Ma, Xiaoyuan Fei, Yuanyue Zhang, Feili Gong, Min Fang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 145-155, DOI:10.1016/j.intimp.2019.01.002 DOI |
| 5. | Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway Author: Yue Huang, Lei Wang, Xiao-xiao Jia, Xi-xi Lin, Wei-xi Zhang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.68, 88-94, DOI:10.1016/j.intimp.2018.12.061 DOI |
| 6. | Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis Author: Meihan Liu, Jingzhe Zhang, Wanguo Liu, Wenjun Wang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, Vol.67, 441-448, DOI:10.1016/j.intimp.2018.12.041 DOI |
| 7. | Adiponectin alleviates exacerbation of airway inflammation and oxidative stress in obesity-related asthma mice partly through AMPK signaling pathway Author: Lili Zhu, Xiuzhen Chen, Lei Chong, Ludan Kong, Shunhang Wen, Hailin Zhang, Weixi Zhang, Changchong Li Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 396-407, DOI:10.1016/j.intimp.2018.12.030 DOI |
| 8. | Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis Author: Xin Rui, Ting-Ting Gu, Hua-Feng Pan, Hui-Zhi Zhang Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 378-385, DOI:10.1016/j.intimp.2018.12.018 DOI |
| 9. | Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice Author: Zuochuan Ding, Dunfeng Du, Yang Yang, Min Yang, Yan Miao, Zhimiao Zou, Xiaoqian Zhang, Zeyang Li, Xue Zhang, Limin Zhang, Xinqiang Wang, Yuanyuan Zhao, Jipin Jiang, Fengchao Jiang, Ping Zhou Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 356-365, DOI:10.1016/j.intimp.2018.11.051 DOI |
| 10. | SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region Author: Yiyang Zhang, Yingshu Li, Jinfeng Li, Biao Li, Yingzhi Chong, Guoying Zheng, Shufeng Sun, Fumin Feng Journal: INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, Vol.67, 348-355, DOI:10.1016/j.intimp.2018.11.054 DOI |
|
| 首页 上一页 1 下一页 尾页 (去 | |
| 以上SCI期刊相关数据和信息来源于网络，仅供参考。 | |
同领域作者分享投稿经验：共12条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 人才招聘
© 2010-2021 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公安备案号：31010402006960
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
